We are live on
!
Find out more
TAM
Tiverton Asset Management Portfolio holdings
AUM
$2.88B
1-Year Est. Return
5.6%
This Fund
S&P 500
This Quarter
Est. Return
+3.06%
1 Year Est. Return
+5.6%
3 Year Est. Return
+61.83%
5 Year Est. Return
+105.31%
10 Year Est. Return
–
AUM
$1.44B
AUM Growth
-$158M
(-9.9%)
Cap. Flow
-$183M
Cap. Flow
% of AUM
-12.74%
Top 10 Holdings %
Top 10 Hldgs %
31.21%
Holding
559
New
43
Increased
116
Reduced
299
Closed
74
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caterpillar
CAT
|
+$8.62M |
| 2 |
Boeing
BA
|
+$7.12M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
+$4.25M |
| 4 |
NVIDIA
NVDA
|
+$4.11M |
| 5 |
Procter & Gamble
PG
|
+$3.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$24.3M |
| 2 |
HEICO Corp Class A
HEI.A
|
+$12.5M |
| 3 |
Pegasystems
PEGA
|
+$8.22M |
| 4 |
Pediatrix Medical
MD
|
+$8.15M |
| 5 |
Nordson
NDSN
|
+$7.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.99% |
| 2 | Healthcare | 17.83% |
| 3 | Consumer Discretionary | 12.33% |
| 4 | Industrials | 12.02% |
| 5 | Financials | 10.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Cencora
COR
$61.2B
| $188K | 0.01% |
2,186
+72
| +3% | +$6.92K |
|
327
KALA BIO
KALA
$14.5M
| $186K | 0.01% |
+5
| New | +$190K |
|
328
Dentsply Sirona
XRAY
$2.43B
| $186K | 0.01% |
3,700
+3
| +0.1% | +$177 |
|
|
GTHX
329
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $186K | 0.01% |
+5,000
| New | +$133K |
|
330
Albemarle
ALB
$15.5B
| $185K | 0.01% |
1,997
+696
| +53% | +$76.7K |
|
331
Dominion Energy
D
$59.3B
| $185K | 0.01% |
2,747
-1,723
| -39% | -$127K |
|
|
CALD
332
DELISTED
Callidus Software, Inc.
CALD
| $184K | 0.01% |
5,129
-15,188
| -75% | -$519K |
|
|
BNY
333
Bank of New York Mellon
BNY
$107B
| $183K | 0.01% |
3,557
-7,407
| -68% | -$412K |
|
334
Cooper Companies
COO
$14.5B
| $183K | 0.01% |
3,200
-312
| -9% | -$18.2K |
|
|
TVRD
335
Tvardi Therapeutics
TVRD
$23.4M
| $183K | 0.01% |
409
-1,228
| -75% | -$596K |
|
336
Martin Marietta Materials
MLM
$33B
| $179K | 0.01% |
862
+267
| +45% | +$57.9K |
|
337
PNC Financial Services
PNC
$101B
| $178K | 0.01% |
1,179
-2,333
| -66% | -$362K |
|
338
VeriSign
VRSN
$26.6B
| $174K | 0.01% |
1,466
-79
| -5% | -$9.15K |
|
|
CA
339
DELISTED
CA, Inc.
CA
| $174K | 0.01% |
5,126
-258
| -5% | -$8.97K |
|
340
Pilgrim's Pride
PPC
$6.54B
| $173K | 0.01% |
+7,026
| New | +$189K |
|
341
IPG Photonics
IPGP
$3.84B
| $171K | 0.01% |
+731
| New | +$180K |
|
342
Cadence Design Systems
CDNS
$93.4B
| $169K | 0.01% |
4,605
-111
| -2% | -$4.53K |
|
343
Universal Health Services
UHS
$10.5B
| $169K | 0.01% |
1,427
-61
| -4% | -$7.24K |
|
344
Synopsys
SNPS
$79.7B
| $168K | 0.01% |
2,023
-103
| -5% | -$9.05K |
|
345
Qorvo
QRVO
$8.74B
| $167K | 0.01% |
2,378
-55
| -2% | -$4.14K |
|
346
FMC
FMC
$1.33B
| $166K | 0.01% |
2,495
+820
| +49% | +$61.1K |
|
347
International Flavors & Fragrances
IFF
$21.9B
| $166K | 0.01% |
1,214
+412
| +51% | +$59.7K |
|
348
Exelon
EXC
$47B
| $163K | 0.01% |
5,862
-3,447
| -37% | -$93.1K |
|
|
VAR
349
DELISTED
Varian Medical Systems, Inc.
VAR
| $163K | 0.01% |
1,333
-59
| -4% | -$7.03K |
|
350
F5
FFIV
$22.7B
| $161K | 0.01% |
1,113
-152
| -12% | -$21.8K |
|
Similar funds
TAM
RCM
NA
FCM
STMM
CC
CA
BA
Tiverton Asset Management's Q1 2018 Portfolio in Review
As of Q1 2018, Tiverton Asset Management held 559 positions worth $1.44B, down 9.9% from $1.6B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Tiverton Asset Management withdrew a net $183M in Q1 2018, closing 74 positions and reducing 299 holdings. Its most notable exit was Tractor Supply, an estimated $2.87M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Tiverton Asset Management opened a new position in Alnylam Pharmaceuticals worth $3.93M.
- Tiverton Asset Management's largest Q1 2018 buy was Alnylam Pharmaceuticals: 33,000 shares worth $3.93M.
- Tiverton Asset Management added most to Caterpillar in Q1 2018, an estimated $8.62M increase.
- Tiverton Asset Management's biggest Q1 2018 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $24.3M.
- Tiverton Asset Management fully exited Tractor Supply in Q1 2018, selling an estimated $2.87M.
- Tiverton Asset Management's ten largest holdings make up 31% of its $1.44B portfolio in Q1 2018.
- Tiverton Asset Management opened 43 new positions and closed 74 in Q1 2018.
- Tiverton Asset Management's portfolio value fell 9.9% quarter-over-quarter to $1.44B.
Based on Tiverton Asset Management's 13F filing for Q1 2018, filed 8 May 2018.